R406 Single Ralimetinib (LY2228820) is a novel

Ralimetinib (LY2228820) is a novel and potent inhibitor of p38 MAPK with IC50 of 7 nM in a cell-free assay

Doxifluridine is an oral prodrug that is converted to the cytotoxic agent 5-fluorouracil (5-FU)

or in making separations where it is necessary to wash the precipitate and redissolve with chemicals which would attack filter paper

thereby reducing the capillary action of the condensed moisture on the sides

Corning These are replacement bodies for the PYREX® 25mL Economy Grade Burets (No

R406 Single Ralimetinib (LY2228820) is a novelR406 is a potent Syk inhibitor with IC50 of 41 nM in cell free assays, strongly inhibits Syk but not Lyn, 5 fold less potent to Flt3. Phase 1.